Stockscreener 앱 받기
4.645
9.28%
-0.475
시간 외 거래:
4.66
0.015
+0.32%
전일 마감가:
$5.12
열려 있는:
$5.03
하루 거래량:
530.25K
Relative Volume:
1.29
시가총액:
$179.21M
수익:
-
순이익/손실:
$-42.05M
주가수익비율:
-1.6472
EPS:
-2.82
순현금흐름:
$-35.26M
1주 성능:
-8.74%
1개월 성능:
-6.35%
6개월 성능:
+29.75%
1년 성능:
+79.34%
1일 변동 폭
$4.43
$5.03
1주일 범위
$4.43
$5.39
52주 변동 폭
$2.21
$10.48
Protara Therapeutics Inc Stock (TARA) Company Profile
명칭
Protara Therapeutics Inc
전화
646-844-0337
주소
345 PARK AVENUE SOUTH, NEW YORK, NY
TARA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TARA
Protara Therapeutics Inc
|
4.645 | 197.54M | 0 | -42.05M | -35.26M | -2.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Protara Therapeutics Inc Stock (TARA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-16 | 개시 | Scotiabank | Sector Outperform |
| 2025-03-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-07-10 | 재개 | Guggenheim | Buy |
| 2021-06-04 | 개시 | H.C. Wainwright | Buy |
| 2021-02-17 | 개시 | Oppenheimer | Outperform |
| 2020-10-19 | 개시 | Cowen | Outperform |
| 2020-07-29 | 개시 | Guggenheim | Buy |
모두보기
Protara Therapeutics Inc 주식(TARA)의 최신 뉴스
Protara (NASDAQ: TARA) named BioSpace 2026 Best Place to Work, small employer category - Stock Titan
Chart based analysis of Protara Therapeutics Inc. trendsGold Moves & Short-Term Trading Alerts - newser.com
Will Protara Therapeutics Inc. stock deliver long term returnsPortfolio Risk Report & Fast Exit and Entry Trade Guides - newser.com
Published on: 2025-11-04 00:31:20 - newser.com
Long term hold vs stop loss in Protara Therapeutics Inc.July 2025 Spike Watch & Real-Time Chart Breakout Alerts - newser.com
Why Protara Therapeutics Inc. (1KPA) stock is listed among top recommendationsMarket Movement Recap & Safe Entry Momentum Tips - newser.com
Will Protara Therapeutics Inc. stock attract more institutional investorsJuly 2025 PostEarnings & Weekly Chart Analysis and Guides - newser.com
Will Protara Therapeutics Inc. stock benefit from upcoming earnings reports2025 Retail Activity & Safe Investment Capital Preservation Plans - newser.com
How Protara Therapeutics Inc. (1KPA) stock reacts to fiscal policies2025 Macro Impact & Weekly Chart Analysis and Guides - newser.com
Why Protara Therapeutics Inc. (1KPA) stock fits value portfolios2025 Top Gainers & Free High Return Stock Watch Alerts - newser.com
Visualizing Protara Therapeutics Inc. stock with heatmaps2025 Year in Review & Free Expert Verified Stock Movement Alerts - newser.com
Real time pattern detection on Protara Therapeutics Inc. stockGold Moves & AI Enhanced Trading Signals - newser.com
Why Protara Therapeutics Inc. stock appeals to analystsWeekly Risk Report & Risk Controlled Daily Plans - newser.com
Can Protara Therapeutics Inc. (1KPA) stock attract analyst upgradesMarket Sentiment Summary & Daily Profit Focused Stock Screening - newser.com
What recovery options are there for Protara Therapeutics Inc.Oil Prices & Smart Swing Trading Alerts - newser.com
Is Protara Therapeutics Inc. stock a safe haven assetVolume Spike & Daily Volume Surge Signals - newser.com
Can technical indicators confirm Protara Therapeutics Inc.’s reversalTrade Analysis Report & Daily Risk Controlled Trade Plans - newser.com
Risk adjusted return profile for Protara Therapeutics Inc. analyzedJuly 2025 Recap & Safe Investment Capital Preservation Plans - newser.com
Will Protara Therapeutics Inc. price bounce be sustainableEarnings Summary Report & Weekly Top Gainers Alerts - newser.com
What is the fair value estimate for Protara Therapeutics Inc. (1KPA) stock in 20252025 Sector Review & Proven Capital Preservation Methods - newser.com
Protara Therapeutics, Inc. (NASDAQ:TARA) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Will Protara Therapeutics Inc. stock rally after Fed decisionsJuly 2025 PreEarnings & Capital Efficient Trade Techniques - newser.com
What analysts say about Protara Therapeutics Inc stockGlobal Trade Effects & Small Entry Investment Ideas - earlytimes.in
Is NINtec Systems Limited Stock Poised for a Breakout in YEARSupport and Resistance Levels & Affordable Growth Trading - earlytimes.in
Protara Therapeutics (NASDAQ:TARA) Trading Down 1.2%Here's What Happened - MarketBeat
How Protara Therapeutics Inc. stock trades during market volatilityWeekly Profit Analysis & AI Forecasted Stock Moves - newser.com
How to read the order book for Protara Therapeutics Inc.July 2025 Update & Safe Entry Point Alerts - newser.com
Measuring Protara Therapeutics Inc.’s beta against major indicesQuarterly Growth Report & Capital Efficient Trading Techniques - newser.com
Is Protara Therapeutics Inc. (1KPA) stock inflation resilient2025 Volatility Report & AI Powered Trade Plan Recommendations - newser.com
Protara Therapeutics Inc (TARA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):